Show simple item record

dc.contributor.authorExecutive Board, 49
dc.coverage.spatialGenevaEN
dc.date.accessioned2014-12-16T13:48:12Z
dc.date.available2014-12-16T13:48:12Z
dc.date.issued1971
dc.identifier.govdocEB49/5
dc.identifier.urihttps://apps.who.int/iris/handle/10665/145553
dc.description(‎Provisional agenda item 2.4)‎EN
dc.language.isoenEN
dc.publisherWorld Health OrganizationEN
dc.subject.meshPharmaceutical PreparationsEN
dc.subject.meshDrug MonitoringEN
dc.subject.meshDrug IndustryEN
dc.subject.meshDrug EvaluationEN
dc.subject.meshQuality ControlEN
dc.subject.meshDrug Information ServicesEN
dc.subject.meshConsumer Health InformationEN
dc.subject.meshPharmacopoeiasEN
dc.subject.meshEducation, MedicalEN
dc.subject.meshDrug TherapyEN
dc.titleQuality, safety and efficacy of drugs: report by the Director-GeneralEN
dc.typeGoverning body documentsEN
dc.subject.meshqualifierstandardsEN
dc.subject.meshqualifiermethodsEN
dc.subject.meshqualifiertrendsEN
dc.subject.meshqualifieradverse effectsEN


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record